Pollak R - Search Results

1

Late acute rejection is more prevalent among African-American renal allograft recipients and is frequently associated with allograft loss.

Vasquez EM, Benedetti E, Pollak R. Vasquez EM, et al. Among authors: pollak r. Transplant Proc. 1998 Jun;30(4):1173-5. doi: 10.1016/s0041-1345(98)00196-1. Transplant Proc. 1998. PMID: 9636474 No abstract available.

2

Effect of calcium channel blockers on graft outcome in cyclosporine-treated renal allograft recipients.

Vasquez EM, Pollak R. Vasquez EM, et al. Among authors: pollak r. Transplantation. 1995 Oct 27;60(8):885-7. Transplantation. 1995. PMID: 7482755 No abstract available.

3

OKT3-induced cytokine-release syndrome: occurrence beyond the second dose and association with rejection severity.

Vasquez EM, Fabrega AJ, Pollak R. Vasquez EM, et al. Among authors: pollak r. Transplant Proc. 1995 Feb;27(1):873-4. Transplant Proc. 1995. PMID: 7879215 No abstract available.

4

High-dose oral acyclovir prophylaxis for primary cytomegalovirus infection in seronegative renal allograft recipients.

Vasquez EM, Sanchez J, Pollak R, Vrahnos D, Fabrega AJ, Maddux MS. Vasquez EM, et al. Among authors: pollak r. Transplantation. 1993 Feb;55(2):448-50. doi: 10.1097/00007890-199302000-00046. Transplantation. 1993. PMID: 8381990 Clinical Trial. No abstract available.

5

Antibody-mediated hemolytic anemia following ABO-mismatched organ transplantation: contributory role of HLA matching and polyclonal antilymphocyte globulin.

Fabrega AJ, DeChristopher J, Sosler SD, Rivas PA, Vasquez EM, Pollak R. Fabrega AJ, et al. Among authors: pollak r. Clin Transplant. 1996 Apr;10(2):166-9. Clin Transplant. 1996. PMID: 8664512

6

Effect of oral pentoxyfylline on the OKT3-induced cytokine-release syndrome among renal allograft recipients.

Vasquez EM, Pollak R. Vasquez EM, et al. Among authors: pollak r. Clin Transplant. 1996 Jun;10(3):294-7. Clin Transplant. 1996. PMID: 8826669 Clinical Trial.

7

Effect of pretransplant erythropoietin therapy on renal allograft outcome.

Vasquez EM, Pollak R. Vasquez EM, et al. Among authors: pollak r. Transplantation. 1996 Oct 15;62(7):1026-8. doi: 10.1097/00007890-199610150-00024. Transplantation. 1996. PMID: 8878400 Clinical Trial.

8

Value of perioperative treatment with sandostatin after pancreas transplantation: a prospective randomized trial.

Benedetti E, Coady NT, Asolati M, Dunn T, Stormoen BM, Raofi V, Vasquez EM, Pollak R. Benedetti E, et al. Among authors: pollak r. Transplant Proc. 1998 Mar;30(2):432-3. doi: 10.1016/s0041-1345(97)01343-2. Transplant Proc. 1998. PMID: 9532115 Clinical Trial. No abstract available.

9

Long-term outcome of kidney transplantation after steroid withdrawal.

Dunn T, Asolati M, Holman D, Raofi V, Lutrin F, Massad M, Pollak R, Benedetti E. Dunn T, et al. Among authors: pollak r. Transplant Proc. 1998 Aug;30(5):1788-9. doi: 10.1016/s0041-1345(98)00432-1. Transplant Proc. 1998. PMID: 9723283 Clinical Trial. No abstract available.

10

Pretransplant MLC in the presence of cyclosporine may predict renal allograft survival.

Holman DM, Dunn TB, Ward M, Raofi V, Jovanovic B, Kumins NH, Lazda VA, Pollak R, Benedetti E. Holman DM, et al. Among authors: pollak r. Transplant Proc. 1999 Feb-Mar;31(1-2):746-7. doi: 10.1016/s0041-1345(98)01752-7. Transplant Proc. 1999. PMID: 10083318 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

240 results

Search Page

Filters